.png)
.png)
Objective: The Turkish Society of Nephrology Registry collects data on hemodialysis, peritoneal dialysis, and transplantation annually. Registry reports are printed every year as a booklet, and this is the 30th year of registry reports. The registry is in close collaboration with international registries.
Material and Methods: In this article, we have summarized data from the 2019 registry report; additionally, we have also provided yearly trends of managing end-stage kidney disease.
Results: The number of patients on renal replacement therapy has increased, and by the end of 2019, 83 738 patients were on renal replacement therapy. The prevalence and incidence of end-stage renal disease were 1007.6 and 150.5 per million population, respectively. Diabetes was the most common cause of end-stage renal disease. Hemodialysis (73.2%) was the most common type of treatment modality, followed by transplantation (22.9%) and peritoneal dialysis (3.9%).
Conclusion: End-stage kidney disease is a critical and growing health problem for our country. The Renal Registry of the Turkish Society of Nephrology is one of the leading tools for providing current and sound data on this public health problem.
Cite this article as: Seyahi N, Ateş K, Süleymanlar G. Current status of renal replacement therapy in turkey: A summary of the 2019 turkish society of nephrology registry report. Turk J Nephrol. 2021; 30(2): 105-111.